
















The Dissertation Committee for Mandy Leigh McCracken Certifies that this is the 
approved version of the following dissertation: 
EVIDENCE OF INTER- AND INTRA-SUBUNIT ALCOHOL AND 
ANESTHETIC BINDING CAVITIES IN THE GLYCINE RECEPTOR  
Committee: 
R. Adron Harris, Supervisor 
Richard Aldrich 
S. John Mihic 
Richard Morrisett 
James Trudell 
EVIDENCE OF INTER- AND INTRA-SUBUNIT ALCOHOL AND 
ANESTHETIC BINDING CAVITIES IN THE GLYCINE RECEPTOR 
by 
Mandy Leigh McCracken, B.S.Psy. 
Dissertation 
Presented to the Faculty of the Graduate School of 
The University of Texas at Austin 
in Partial Fulfillment  
of the Requirements 
for the Degree of  
Doctor of Philosophy 




 To the millions of people personally afflicted by alcohol abuse and dependence 
and to the family and friends who have helplessly had to stand by and watch loved ones 
as they suffered the effects of this insidious disease, I dedicate this to you. 
As scientists, we understand the reality of your challenges and we are committed 
to helping advance the development of improved treatment options through our pursuit of 







As legendary coach Vince Lombardi said, “People who work together will win, 
whether it be against complex football defenses, or the problems of modern society.”  
Although this endeavor has not involved overcoming any complex football defenses, it 
has involved overcoming some unique “problems of modern society” while 
simultaneously negotiating the ordinary challenges associated with pursuing a doctoral 
degree in basic science. Fortunately though, I have been surrounded by a number of 
special people who have helped to make this possible by working with me so we could 
“win,” despite the unique “problems of modern society” that affected me personally at 
different points along the way. 
To my research adviser, Dr. R. Adron Harris, I am infinitely grateful for your 
support of undergraduate research and belief in me as a young scientist when I began 
working in your lab at just 19 years of age. The weekly meetings, guidance, and expertise 
invested back then through your service as my undergraduate honors thesis adviser, my 
University Junior Fellows Honors Program mentor, and supervisor/sponsor on 4 separate 
undergraduate research grants had an early impact and truly helped to shape me as a 
scientist. Your unwaivering commitment, contagious enthusiasm for science, and 
consistently high standards have encouraged the best out of me and will forever serve as 
a positive example. Admittedly, when I look back at the opportunities you and your lab 
have afforded me over the years, both as an undergraduate and a graduate student, I 
realize just how privileged I have been. For your incredible patience, flexibility, 
accommodations, concern, and continued endorsement, even after my diagnosis and 
multiple medical adversities, I am thankful beyond words. 
 vi 
I would also like to acknowledge my other committee members: Dr. James 
Trudell, Dr. S. John Mihic, Dr. Richard Morrisett, and Dr. Richard Aldrich. I am 
sincerely grateful for the time, understanding, and guidance provided by each of you. Dr. 
Trudell, your willingness to travel from Stanford University for meetings and my defense 
has been particularly appreciated. You have become a valuable resource and provided me 
with insights through our collaborations that have not only enriched our publications, but 
enabled me to approach research questions and hypotheses that otherwise may not have 
been addressed or explored. John Mihic, you have been a constant presence during my 
undergraduate and graduate studies, always ready to intercept my questions with your 
quick wit and respond with an even deeper, “deep thought” question. Your ability to 
provide comic relief, but not at the expense of quality science, is a true gift. And your 
enduring optimism and dedication to the students’ best interest, whether it be inside or 
outside of academia, is always encouraging. It is difficult to imagine working next door 
to any other “lab neighbor” besides the Mihic Lab! Dr. Morrisett, I am grateful for your 
participation on all 3 of my committees during graduate school (pre-proposal, qualifying, 
and now dissertation). Not only have you asked challenging questions when they needed 
to be asked and helped to keep me motivated to perform at my best, but you have also 
been fair and made meaningful suggestions about my project and data.  Dr. Aldrich, I 
genuinely appreciate your accessibility to students, and the thorough manner in which 
you approach science. Your questions and contributions have encouraged me to think 
about my project and the meaning of my data from an additional perspective.  
 vii 
Although not formally a part of my dissertation committee, there are several 
additional people affiliated with The University of Texas at Austin (current or past) who I 
would like to acknowledge as well. Dr. Cecilia Borghese kindly provided me with much 
of the initial technical training, particularly in site-direct mutagenesis and two-electrode 
voltage clamp electrophysiology, I received when I began working in the Harris Lab as 
an undergraduate. I am infinitely grateful for the time she dedicated to helping me learn, 
and her continued interest in my progress to this day. Without the proteomic insight, 
technical expertise, and collaboration of Dr. Dayne Mayfield, Dr. Giorgio Gorini, and Dr. 
Yury Nuñez, the completion of the immunoblotting and mass spectrometry in this project 
would not have been possible. Their willingness to forge ahead and encouragement 
helped me to believe success was still possible, even in light of the many technical and 
experimental frustrations initially encountered. The enduring friendships of Drs. Gorini 
and Nuñez are also something I will take with me and value from this experience. 
Moreover, I am forever thankful for the guidance and urging of Dr. Deborah Stote, 
without whom I may not have ever found the Waggoner Center for Alcohol and 
Addiction Research or Dr. Harris, and consequently, had the opportunity to pursue to my 
true research interests and goals as both an undergraduate and graduate student. 
Furthermore, I am appreciative of the Harris Lab members, past and present, for creating 
a collaborative, collegial, and often social, work environment.  I am the last of a “cohort” 
of graduate students in the Harris Lab who began at similar times, attended several 
courses together, and progressed through our respective program milestones one after 
another. We experienced most of this journey together, and I am thankful to them for 
 viii 
their wisdom as I finish this chapter of my education and move onto a postdoctoral 
position. To Dr. Chang Hoon Lee, thank you for your friendship and helping to keep me 
laughing and fed on a daily basis. To my twin sister Dr. Lindsay McCracken, thank you 
for keeping me continuously motivated and always challenging me not to be second best. 
I am also grateful to Debra James (past) and Jayna Dixon. Without their knowledge and 
skills, the Waggoner Center and Harris Lab would not run so efficiently, nor would it be 
as enjoyable a place to work.  
 Additionally, I want to acknowledge my parents, Edward and Lisa, for their 
unconditional love and support. I am sincerely grateful for all of the opportunities and 
resources you have provided me since childhood, so that I could find and cultivate my 
interests and passion and pursue my dreams. Thank you for celebrating my greatest 
accomplishments, standing by me at my worst, and teaching me the difference between 
playing to win versus playing not to lose.  
Finally, I would like to acknowledge all of the many healthcare professionals who 
have participated in my care since my diagnosis. Each of their unique expertise and 
dedication have made this physically possible for me. Specifically, I have had the 
privilege to be a patient in the renowned neurology and neurosurgery service at UCSF 
Medical Center, and I will be forever grateful for the exemplary care I have received 
there. I am particularly indebted to my neurologists Dr. Peter Goadsby and Dr. Abraham 
Nagy as well as my neurosurgeons Dr. Nicholas Barbaro, Dr. Manish Aghi, and Dr. 
Michael McDermott. Not only have they made my physical well-being a top priority, but 
I am exceptionally fortunate for their support, understanding, and willingness to share 
 ix 
and accommodate my academic and career goals, especially the completion of this 
endeavor. It is due to the forging of our partnership that I have been physically able to 
continue my pursuit of a doctoral degree and a career in science. In addition, I have much 
gratitude for the contributions of Dr. Babak Larian in the Center for Advanced Head & 
Neck Surgery and Dr. Babak Azizzadeh in the Center for Advanced Facial Plastic & 
Reconstructive Surgery at Cedars Sinai Medical Center in Los Angeles. Their remarkable 
diagnostic and surgical skills as well as their first-rate bedside manner, especially over 
the last 9 months, have complimented my care at UCSF Medical Center and have given 
hope and provided improvement to what was an increasingly painful and frustrating 
situation. Lastly, the willingness of local physicians and surgeons in Austin to collaborate 
in my care has helped to reduce travel, and ultimately allowed me the time necessary on 
The University of Texas campus to complete this project. These individuals include: Dr. 
Vivek Mahendru and his associates at the Pain Specialists of Austin, especially Dr. 
Christopher Manees. Drs. Mahendru and Manees have worked tirelessly to help minimize 
my discomfort, but not with the total loss of my cognitive functioning. I am also grateful 
to plastic surgeon Dr. Jennifer Walden for her repeated willingness to collaborate with 
my other surgeons, especially those in California, to ensure that my surgical outcomes are 






EVIDENCE OF INTER- AND INTRA-SUBUNIT ALCOHOL AND 
ANESTHETIC BINDING CAVITIES IN THE GLYCINE RECEPTOR  
 
Mandy Leigh McCracken, Ph.D. 
The University of Texas at Austin, 2014 
 
Supervisor:  R. Adron Harris 
 
Alcohol is abundantly consumed by society and general anesthetics are used 
everyday in operating suites throughout the world, yet the sites and mechanisms of action 
for these drugs are not completely understood. Glycine receptors (GlyRs) are pentameric 
ion channels expressed throughout the brain and spinal cord and have become 
increasingly popular targets in the study of alcohol action. Each GlyR subunit is 
composed of four alpha helical transmembrane segments (TM1-4), and although amino 
acids involved with alcohol action have been previously identified in TM1-4, the 
orientation of each of these residues with respect to a putative alcohol/anesthetic binding 
cavity remains controversial. In order to better characterize this binding cavity within the 
GlyR, we conducted a series of experiments using cysteine mutagenesis and biochemical 
cross-linking. In Aim 1, the participation of TM1 with TM3 in a common 
alcohol/anesthetic binding cavity was further investigated. We used two-electrode voltage 
clamp electrophysiology in Xenopus oocytes to demonstrate the ability of A288 in TM3 
to form cross-links with I229 in TM1, which reduced the ability of both alcohol and 
anesthetics to modulate GlyR function.  Aim 2 investigated whether TM3 could also 
participate in a binding cavity with TM4. We have shown that residues in TM4 are able 
to form cross-links with A288 in TM3, and found that cross-linking between TM3 and 
 xi 
those residues in TM4 also reduced the ability of alcohol and anesthetics to enhance 
GlyR function. Aim 3 determined whether these cross-links are formed between residues 
within the same subunit (intra-subunit) or between subunits (inter-subunit), and 
ultimately whether these residues participate in a common alcohol/anesthetic binding 
cavity within or between GlyR subunits. GlyR protein, which measures about 50 kDa, 
was extracted from oocytes injected with the cysteine mutants, and immunoblotting was 
used with a GlyR-specific antibody to subsequently help quantify band ratios between 
cross-linked and uncross-linked conditions. We found an increase in the 100:50 kDa band 
ratio for the TM1-3 mutant only, but not TM3-4 mutant or the wild-type, which suggests 
TM1-3 may participate in an alcohol binding cavity between GlyR subunits while TM3-4 
may contribute to a binding cavity within a subunit. 
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CHAPTER I: Background and Significance 
 
Despite the frequent consumption of alcohol in our society and the common use 
of general anesthetics in operating suites, scientists and healthcare providers are only 
beginning to understand how these drug molecules interact with molecular targets to 
produce physiological and behavioral effects.  Alcohol, like anesthetics, is a CNS 
depressant capable of producing a range of dose-dependent physiological and behavioral 
effects beginning with low-dose disinhibition and anxiolytic properties followed by 
moderate-dose amnestic and other cognitive impairments. Finally, alcohol and 
anesthetics share similar high-dose end points including sedation, the induction of 
anesthesia, coma, and in severe circumstances, even death. 
Originally, it was proposed that both alcohol and anesthetics exert their effects 
through action at lipid membranes (Janoff et al., 1981; Lyon et al., 1981), however a 
more current and widely accepted view is that these drug molecules act by binding 
directly to a number of proteins in the central nervous system (CNS), including glycine 
receptors (GlyRs) (Harris et al., 2008). GlyRs not only mediate the majority of inhibitory 
neurotransmission in the brain stem and spinal cord (Legendre, 2001), but they are also 
expressed in other brain regions including the olfactory bulb, hippocampus, nucleus 
accumbens (van den Pol and Gorces, 1988; Fatima-Shad and Barry, 1993; Molander and 




THE GLYR STRUCTURE 
GlyRs are members of the Cys-loop family of ligand-gated ion channels, which 
also includes the nicotinic acetylcholine receptor (nAChR), the serotonin 3 receptor (5-
HT3R), and γ-aminobutyric acid type A (GABAA). Functional receptors are composed of 
five homologous subunits positioned around a central chloride channel, with the structure 
of each subunit consisting of an extracellular N-terminal domain, a transmembrane 
domain with four alpha helical segments (TM1, TM2, TM3, and TM4), an intracellular 
loop between TM3 and TM4, and an extracellular C-terminal domain (Figure 1.1). The 
glycine agonist binding site is located extracellularly at the interface between adjacent 
GlyR subunits, where pairs of oppositely charged residues on each side of the interface 
form optimal conditions for glycine binding (Grudzinska et al., 2005). The coupling of 
glycine agonist binding and channel gating has been proposed to involve an interaction of 
the TM2-TM3 linker region with the β1-β2 loop and the Cys loop (Kash et al., 2003). In 
addition, GlyRs can be gated by lower efficacy agonists such as taurine and β-alanine, 
however these agonists likely exert their effects through similar, but distinct, mechanisms 
from that of glycine (Pless et al., 2011).  
Four GlyR α subunits (α1-4) and a single β subunit have been identified 
(Grenningloh et al., 1990; Harvey et al., 2000; Harvey et al., 2004).  There is 80-90% 




Figure 1.1. Representative 3D Structure of a ligand-gated ion channel. The extracellular 
domain (ECD) is depicted in red, transmembrane domain (TMD) in purple, and 
cytoplasmic domain (CD) or intracellular loop in green. In the absence of an x-ray crystal 
structure, GlyR homology models are built using related proteins with known sequences 
and structures as a template. The Torpedo nAChR was used as a template for the 
pentamer illustrated here (Adapted from Baenziger and Corringer, 2011).  
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subunit and the α subunits.  GlyR subunits can assemble to form either homomeric α 
receptors or heteromeric αβ receptors (Lynch, 2004).   
 Although a complete high resolution GlyR crystal structure has not yet been 
solved, medium to high resolution structures exist for related ligand-gated ion channel 
motifs, including the acetylcholine binding protein (AChBP) (Brecj et al., 2001; Celie et 
al., 2004) and the Torpedo nAChR (Unwin, 2005).  Additionally, the crystal structures 
for two prokaryotic homologues, Erwinia chrysanthemi (ELIC) and Gloebacter violaceus 
(GLIC) (Hilf and Dutzler, 2008; Hilf and Dutlzer, 2009; Bocquet et al., 2009), and the 
invertebrate Caenorhabditis elegans glutamate-gated chloride channel (GluCl) (Hibbs and 
Gouaux, 2011) have provided improved templates and better informed homology 
modeling for the study of GlyRs and related mammalian ion channels. Most recently, 
Mowrey et al. (2013) used full-length nuclear magnetic resonance (NMR) spectroscopy 
and electron micrographs to produce specific structural information from the expressed 
hGlyR-α1 TM domain. This lower resolution structural information, specifically from the 
GlyR, combined with the known homologue structures and experimental data from 
studies in heterologous expression systems should help to provide ongoing insight and 
more detailed, higher resolution information regarding GlyR structure. 
 
THE GLYR, ALCOHOL, AND ANESTHETICS 
Alcohols and volatile anesthetics were initially hypothesized to produce their 
effects through action at the lipid bilayer of cell membranes.  This lipid hypothesis was 
 5 
based on the early observation that volatile anesthetic potency strongly correlated with 
the ability of anesthetics to partition into olive oil (Meyer, 1899; Overton, 1901).  More 
recently however, there has been accumulating evidence that these drug molecules 
instead bind to specific proteins (Franks and Lieb, 1984; Mihic et al., 1997), and 
currently, the protein sites of action theory is the predominant view (Harris et al., 2008).  
In addition, experimental evidence has shown that alcohols and volatile anesthetics likely 
share common sites of action in the GlyR (Mihic et al., 1997; Beckstead et al., 2001; 
Jenkins et al., 2001) and act as positive allosteric modulators (Harrison et al., 1993; 
Mascia et al., 1996). 
Initial studies using heterologous expression systems, site-directed mutagenesis, 
and alkyl thiol reagents identified two critical amino acid residues for alcohol and 
anesthetic enhancement in GlyR TM2 and TM3. These include serine-267 (S267) and 
alanine-288 (A288) in TM2 and TM3, respectively (Mihic et al., 1997; Mascia et al. 
2000). Additional experiments suggested that these residues along with isoleucine-229 
(I229) from TM1 and others from TM4 likely participate in a common alcohol/anesthetic 
binding cavity (Jenkins et al., 2001; Lobo et al., 2004a; Lobo et al., 2006; McCracken et 
al., 2010).  
More recently, Borghese et al. (2012) have also shown that mutation of residues 
neighboring the critical S267 site in TM2, glutamine-266 (Q266), and methionine-287 
(M287) also eliminates alcohol enhancement of GlyR function. In addition to the 
aforementioned TM sites, other putative alcohol binding sites have also been proposed in 
the α1 GlyR, including alanine-52 (A52) in loop 2 of the N-terminal domain (Davies et 
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al., 2004; Crawford et al., 2008) and lysine-385 (K385) in the intracellular loop linking 
TM3 and TM4, which has been proposed to be involved in GlyR modulation by Gβγ 
(Yvenes et al., 2003; Yvenes et al., 2008). 
 
CROSS-LINKING OF GLYR TRANSMEMBRANE SEGMENTS 
 Given that specific amino acid residues within the TM domain appear to be 
crucial for GlyR modulation by alcohols and anesthetics, investigating the proximity and 
orientation of these residues to each other as well as a putative alcohol/anesthetic-binding 
cavity is imperative in order to better understand alcohol and anesthetic action at GlyRs.  
The proximity and relative orientation of TM residues of interest can be investigated by 
substituting cysteine at each position, and subsequently testing whether or not they are 
able to form biochemical cross-links with one another. Residues of interest must be 
located on opposing helices in order to form cross-links, and typically their Cα carbons 
cannot be separated by greater than 15 Α (Lee et al., 1995; Yang et al., 1996; Struthers et 
al., 2000; Soskine et al. 2002; Winston et al., 2005).  
Due to the current absence of a GlyR crystal structure, there are multiple 
hypotheses regarding the site of alcohol- and anesthetic-binding within the GlyR TM 
domain. One hypothesis suggests that I229 in TM1, S267 in TM2, A288 in TM3 and 
others from TM4 may contribute a hydrophilic alcohol/anesthetic binding site within a 
GlyR subunit (intra-subunit). This intra-subunit hypothesis is supported by 
electrophysiology studies in heterologous expression systems using the substituted 
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cysteine accessibility method (SCAM) as well as initial cross-linking findings in GlyRs 
and homology modeling (Williams & Akabas, 1999; Yamakura et al., 2001; Lobo et al., 
2004a; Lobo et al., 2004b; Lobo et al., 2006). In addition, x-ray structures of general 
anesthetics bound to the prokaryotic homologue GLIC support binding and modulation at 
an intra-subunit cavity (Nury et al., 2009).  A second hypothesis has been proposed 
suggesting that the critical TM residues are positioned such that anesthetics instead bind 
at the interface between two adjacent subunits (inter-subunit). This inter-subunit 
hypothesis was first based on similar studies in the GABAA receptor to those described 
above in the GlyR (Bali et al., 2009) and has been recently supported by crystallography 
work paired with functional studies in GLIC which determined and compared the crystal 
structures of ethanol-treated and non-ethanol treated receptors (Sauguet et al., 2013).  
Finally, a third “multisite” hypothesis has emerged suggesting that perhaps alcohols and 
anesthetics may, in fact, bind and act at both intra-subunit and inter-subunit sites within 
these receptor proteins. This hypothesis has been generated largely from mutagenesis 
studies in the GLIC and GluCl homologues, molecular simulations, and newer homology 
modeling (Howard et al. 2011; Murail et al., 2012; Yoluk et al., 2013). In addition, recent 
structural information obtained from full-length nuclear magnetic resonance (NMR) 
spectroscopy and electron micrographs using expressed hGlyR-α1 TM domain 
demonstrated a considerable degree of flexibility at the extracellular end of the pore 
(Mowrey et al., 2013), allowing residue A288 in TM3 to possibly participate in both an 
intra-subunit and inter-subunit drug bind cavity in the GlyR. Recent cross-linking studies 
in the mammalian GABAA receptor also provide additional support for the “multisite” 
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hypothesis, but suggest that the effects may be influenced by receptor type and state as 
well as differentially affected by alcohols and anesthetics (Borghese et al., 2014).  
 
GAPS IN OUR KNOWLEDGE 
 Despite accumulating evidence for the role of TM amino acid residues in alcohol 
and anesthetic enhancement of the α1 GlyR, several unknowns remain with regard to the 
contribution of these residues to a putative alcohol/anesthetic-binding pocket. First, in the 
absence of a GlyR crystal structure, the proximity and relative orientation of the critical 
TM amino acid residues involved with alcohol/anesthetic action has not been fully 
elucidated, and it is presently unknown whether the critical residues in TM1-3 contribute 
to an intra-subunit binding pocket within the TM domain of each GlyR subunit, form an 
inter-subunit pocket at the subunit interface as some have proposed in the GABAAR and 
shown in prokaryotic homologues, or alternatively, contribute to both an intra- and inter-
subunit binding pocket (Figure 1.2). Moreover, because the involvement of TM4 in 
alcohol and anesthetic action has been much less studied than TM1-3, the significance of 
its contribution to a putative alcohol/anesthetic binding pocket remains less clear. This 
dissertation contains three aims that will address these areas and will contribute to a more 





1. To investigate whether TM1 participates in a common alcohol and anesthetic binding 
cavity with TM3. 
2. To examine whether TM3 participates in a common alcohol and anesthetic binding 
cavity with TM4. 
3. To determine whether the critical sites for alcohol and anesthetic action in TM1-4 are 
oriented to form a binding cavity within the same subunit (intra-subunit), between 





Figure 1.2. Putative alcohol and anesthetic binding sites. A) Inter-subunit cavities located 
at the interface between adjacent subunits are depicted in red on using a representative 
Cys-loop ion channel. B) Intra-subunit cavities are depicted in blue at the center of the 




CHAPTER II: Biochemical Cross-linking Provides Evidence that 
Glycine Receptor Transmembrane Segments 1 and 3 Participate in a 
Common Inter-subunit Alcohol and Volatile Anesthetic Binding Cavity 
 
INTRODUCTION 
 Strychnine-sensitive glycine receptors (GlyRs), like other proteins in the central 
nervous system (CNS), have become the focus of investigations into the sites of action 
for alcohol and anesthetics. They belong to the Cys-loop superfamily of ligand-gated ion 
channels, which also includes nicotinic acetylcholine receptor (nAChR), the serotonin 3 
receptor (5-HT3R), and the γ-aminobutyric acid type A receptor (GABAAR). GlyRs 
mediate inhibitory neurotransmission in the CNS through their expression in the 
brainstem and spinal cord (Legendre et al., 2001) as well as in areas of the amygdala, 
cortex, hippocampus, striatum, ventral tegmental area (Jonsson et al., 2009; Baer et al., 
2009), and cerebellum (Takahashi et al., 1992).  
 Functional GlyRs consist of five homologous protein subunits positioned around a 
central chloride channel, with the glycine agonist binding site located extracellularly at 
the subunit interface where pairs of oppositely charged residues promote glycine binding 
(Grudzinska et al., 2005). Structurally, each subunit is composed of an extracellular N-
terminal domain, a transmembrane domain with four alpha helical segments (TM1, TM2, 
TM3, and TM4), an intracellular loop between TM3 and TM4, and an extracellular C-
terminal domain. A single β and four α GlyR subunits (1-4) have been identified 
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(Grenningloh et al., 1990; Harvey et al., 2000; Harvey et al., 2004), which can assemble 
to form functional homomeric α receptors or heteromeric αβ receptors (Lynch, 2004).  
 The GlyR is a common site of action for alcohols and anesthetics (Mihic et al. 
1997; Mascia et al., 2000; Beckstead et al., 2001; Borghese et al., 2012), and both drugs 
positively modulate GlyR function (Harrison et al., 1993; Mascia et al., 1996). Studies 
using site-directed mutagenesis and alkyl thiol reagents have identified critical amino 
acid residues for alcohol and anesthetic action in TM1-4 of the GlyR and suggest these 
residues may contribute to water-filled alcohol/anesthetic-binding cavity (Mascia et al., 
2000; Jenkins et al, 2001; Lobo et al., 2004a; Lobo et al., 2006). In addition, studies using 
cysteine mutagenesis and cross-linking agents have shown that A288 in TM3 is able to 
form cross-links with each of the critical residues for alcohol and anesthetic action in 
TM1 (I229) (Lobo et al., 2008) (Figure 2.1) , TM2 (S267) (Lobo et al., 2004b), and TM4 
(Y406, W407, I409, and Y410) (McCracken et al., 2010). Moreover, cross-linking of 
A288 in TM3 with 267 in TM2 has been shown to significantly reduce alcohol or volatile 
anesthetic potentiation of GlyR function (Lobo et al., 2004b), providing further evidence 
that S267 and A288 together likely participate in an alcohol/anesthetic binding cavity. 
However in the absence of a high resolution GlyR crystal structure, the specific 
orientation of these critical residues, particularly A288 in TM3, remains controversial. 
 Initial medium to high resolution information from related ligand-gated ion 
channel motifs, including the acetylcholine binding protein (AChBP) (Brecj et al., 2001; 
Celie et al., 2004) and the Torpedo nAChR (Unwin, 2005), provided useful structural 




Figure 2.1. Effect of Oxidation with iodine and reduction with DTT on GlyRs. A) WT 
representative tracing demonstrating that glycine response is altered following the 
application of 0.5 mM iodine or 10 mM DTT. B) The glycine response of the 
I229C/A288C double mutant is markedly reduced following oxidation by iodine. 
However, the effect is reduced by DTT (Adapted from Lobo et al., 2008).  
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predicted that critical amino acids in all four GlyR TM segments faced into a water-filled 
alcohol/anesthetic binding cavity within an intra-subunit alpha helical bundle (Bertacini 
et al., 2005; Ernst et al., 2005; Young et al., 2008). This intra-subunit prediction is 
consistent, at least in part, with the cross-linking findings from the GlyR demonstrating 
the ability of A288 in TM3 to form cross-links with each of the critical alcohol/anesthetic 
residues in the other TM segments.  More recently, the x-ray structures have been solved 
for two prokaryotic homologues, Erwinia chrysanthemi (ELIC) and Gloebacter violaceus 
(GLIC) (Hilf and Dutzler, 2008; Hilf and Dutlzer, 2009; Bocquet et al., 2009), and the 
invertebrate Caenorhabditis elegans glutamate-gated chloride channel (GluCl) (Hibbs and 
Gouaux, 2011). While x-ray structures of general anesthetics bound to the prokaryotic 
homologue GLIC support binding and modulation at an intra-subunit cavity (Nury et al., 
2009), functional and structural studies in GLIC using ethanol and bromo-ethanol instead 
propose an alternative inter-subunit hypothesis whereby alcohol action is primarily 
occurring at the interface of two adjacent subunits (Sauguet et al., 2013). A third 
“multisite” hypothesis has also been generated based on mutagenesis studies in the GLIC 
and GluCl homologues, molecular simulations, and newer homology models. The 
multisite hypothesis posits that alcohols and anesthetics may, in fact, act at both inter-
subunit and intra-subunit sites within these protein receptors (Howard et al. 2011; Murail 
et al., 2012; Yoluk et al., 2013). Therefore, the aim of the present study was to investigate 
whether 1229 in TM1 and A288 in TM3 are participating in a common alcohol/anesthetic 
binding cavity, and to determine whether the cavity is within a GlyR subunit or between 
adjacent subunits. 
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MATERIALS AND METHODS 
Materials  
All chemical reagents and buffer constituents were purchased from Sigma-Aldrich 
(St. Louis, MO), and were prepared immediately before use. Adult female Xenopus 
laevis frogs were purchased from Nasco (Ft. Atkinson, WI). 
Site-directed Mutagenesis 
 A QuickChange site-directed mutagenesis kit (Stratagene, La Jolla, CA) was used 
to make point mutations in the human glycine receptor α1 subunit (subcloned in the 
pBKCMV N/B-200 vector). Specifically, the I229C and A288C single mutants were 
constructed.  Additionally, the I229C/A288C, and I229C/C290S double mutants and the 
I229C/A288C/C290S triple mutant were engineered. All point mutations were verified by 
DNA sequencing in the core facility at the University of Texas at Austin. 
 
Oocyte Isolation and cDNA Injection 
 Portions of ovary were surgically extracted from adult female Xenopus laevis 
frogs. Mature oocytes were manually isolated, treated in 0.5 mg/ml collagenase (type IA), 
and subsequently injected into the nucleus with 30 nl of nuclease-free water and cDNA 
(1.5 ng/30 nl) encoding either wild-type or mutant human α1 glycine receptors.  Injected 
oocytes were incubated at 13°C in sterile modified Barth’s solution (MBS) (88 mM 
NaCl, 1 mM KCl, 2.4 mM NaHCO3, 19 mM HEPES, 0.82 mM MgSO4, 0.33 mM 
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Ca(NO3)2, 0.91 mM CaCl2, 10,000 units/liter penicillin, 50 mg/liter gentamicin, 90 
mg/liter theophylline, 220 mg/liter sodium pyruvate, pH 7.5) for 1-7 days. 
 
Electrophysiological Recording 
 Two-electrode voltage clamp electrophysiology was used to measure glycine-
induced current from oocytes 1-7 days following injection with cDNAs.  Oocytes were 
place in a rectangular chamber (~ 100 µl) and continuously perfused at a rate of 2 ml/min 
with MBS at 13°C.  A -70 mV holding potential was achieved using to two glass 
electrodes containing 3 M KCl and a Warner Instrument oocyte clamp (Hamden, CT).  
All solutions were prepared immediately before use and applied by bath perfusion. 
Alcohol or Volatile anesthetic potentiation. A glycine EC5-10 (the concentration 
that produced 5-10% of the maximal response) was determined for each oocyte after 
application of the maximal glycine concentration and served as the test glycine 
concentration.  All test glycine concentrations were applied for 30 s and were followed 
by a 5 min washout.  Oocytes received two consecutive applications of the test glycine 
concentration to ensure that responses were stable.  Alcohols or anesthetics were pre-
applied for 1 min alone and then co-applied with glycine for 30 s.  All drug applications 
were immediately followed by a 10 min washout.  The test glycine concentration was 
applied again, and the percent potentiation of the glycine-induced current by the alcohol 
or anesthetic was calculated for each oocyte.  10 µM HgCl2 was applied for 1 min in the 
presence of 100 mM glycine (maximal) and followed by a 15 min washout.  Afterward, 
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the maximal glycine concentration was re-applied and the test concentration (EC5-10) was 
recalculated.  The potentiation of glycine-induced current by the alcohol or anesthetic 
was then measured again as described above.  This protocol was used to test 22 mM 
butanol and 0.6 mM isoflurane, which corresponds to approximately two times the 
minimal alveolar concentration (MAC) for these drugs. 
Oxidation with H2O2 and Reduction with DTT. The maximal glycine 
concentration (100 mM) was applied for 15-20 s and followed by a 15 min washout. This 
was repeated and the second glycine response served at the test glycine response for this 
experiment. 0.5% H2O2 was then applied in the presence of maximal glycine (100 mM) 
for 1 min. and then washed out for 15 min. The oocytes were unclamped during 
application and washout of the oxidizing agent to maintain health, but remained impaled 
by the electrodes as previously described in Lobo et al. 2008 and McCracken et al. 2010. 
After re-clamping, maximal glycine was re-applied and the responses were compared to 
the initial glycine test response prior to H2O2 application. Maximal glycine was applied a 
second time and served as the new test glycine response. 10 mM dithiothreitol (DTT) was 
applied for 3 min while oocytes were unclamped as described above for the cross-linking 
agents and washed out for 15 min and re-clamped. Maximal glycine was re-applied and 
the responses were compared to the second glycine test response following H2O2 
application. 
Data Analysis. For each receptor tested in the experiments using HgCl2, repeated-
measures t-tests were used to detect differences before and after cross-linking (i.e. pre-
HgCl2 vs post-HgCl2) conditions. For the additional cross-linking experiments using the 
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oxidizing agent H2O2 and reducing agent DTT, a one-way ANOVA with Tukey’s post-
test was used to detect significant differences between conditions (pre- H2O2 vs post- 
H2O2 vs post-DTT). GraphPad PRISM software (San Diego, CA) was used for all 
analyses, and statistical significance was determined at p < 0.05. 
 
Protein Extraction 
Individual oocytes were manually isolated and injected with 1.5 ng/nl cDNA as 
described above. Injected oocytes were incubated for 5-7 days at 13°C. Groups of 25 
oocytes were pooled for each condition. Those included in the cross-linked condition 
were treated with 0.5 % H2O2 by bath perfusion as described in McCracken et al. 2010 
and as described for the HgCl2 application above in the electrophysiology experiments. 
Following a 15 min washout, oocytes were homogenized in 1 mL of Wash Buffer (0.1M 
EDTA, pH 7.5; 0.1 M EGTA, pH 7.5; 2M NaCl; 0.1M NaH2PO4, pH 7.5) with protease 
inhibitors (5 mM benzamidine; 15 mM iodoacetamide), and then centrifuged at 4°C for 
30 min at 13500 rpm. The supernatant was removed, and 250 µL of Extraction Buffer 
(wash buffer described above + 2% Triton + 5 mM benzamidine + 15 mM 
iodoacetamide) was added. The pellet was resuspended, rotated at 4°C for 2 hrs, and then 
centrifuged at 4°C for 30 min at 13500 rpm. The supernatant was removed and saved as 
the protein extract. Similar protein extract protocols using Xenopus oocytes have been 




Equal amounts of soluble proteins (unless otherwise noted) extracted from 
oocytes were resolved by SDS-PAGE and electrotransferred to polyvinylidene fluoride 
membrane in a buffer containing 25 mM Tris, 192 mM glycine, 0.1% (w/v) SDS, and 
20% (v/v) methanol for 1 h at 18 V. Membranes were briefly rinsed in a buffer 
containing 10 mM Tris HCl (pH 8.0), 150 mM NaCl and 0.01% (v/v) Tween-20 (TBS-
T), and then incubated at room temperature for 1 h in TBS-T containing 5% (w/v) 
skimmed milk powder to block non-specific binding of antibodies. Incubation of 
membranes with specific primary antibody for GlyR α1 (AbCam, Cambridge, England) 
was performed in TBS-T containing 1% skimmed milk and 1% BSA powders (w/v) for 2 
h at room temperature, followed by three 10 min washes with TBS-T alone. Membranes 
were then incubated for 1 h at room temperature with an appropriate secondary antibody 
conjugated to horseradish peroxidase (HRP), diluted in TBS-T /1% (w/v) skimmed milk 
and BSA powders, followed by three 5 min washes with TBS-T. After the final wash, 
blots were immediately developed by applying the Enhanced Chemi-Luminescence 
(ECL) reagent (Pierce Chemical Co., Rockford, IL) for 2 min, and then a Kodak Image 
Station 2000MM (Eastman Kodak, Rochester, NY) was used to acquire images. 
 
Protein Identification by Mass Spectrometry 
Gel bands of interest were excised and washed 3 times then digested in-gel with 
modified porcine trypsin protease (Promega, Fitchburg, WI). The digested tryptic 
peptides were desalted using a Zip-tip C18 (Millipore, Billerica, MA). Peptides were 
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eluted from the Zip-tip with 0.5μL of matrix solution (α-cyano-4-hydroxycinnamic acid, 
5 mg/mL in 50% acetonitrile, 0.1% trifluoroacetic acid, 25mM ammonium bicarbonate) 
and spotted on a MALDI plate. 
Mass Spectrometry. MALDI-TOF MS and TOF/TOF tandem MS/MS were 
performed on AB SCIEX TOF/TOF™ 5800 System (AB SCIEX). MALDI-TOF mass 
spectra were acquired in reflectron positive ion mode, averaging 4000 laser shots per 
spectrum. TOF/TOF tandem MS fragmentation spectra were acquired for each sample, 
averaging 4000 laser shots per fragmentation spectrum on each of the 7-10 most 
abundant ions present in each sample (excluding trypsin autolytic peptides and other 
known background ions). 
Database search. Both the resulting peptide mass and the associated fragmentation 
spectra were submitted to GPS Explorer workstation equipped with MASCOT search 
engine (Matrix Science, Boston, MA) to search the Swiss-Prot database. Searches were 
performed without constraining protein molecular weight or isoelectric point, with 
variable carbamidomethylation of cysteine and oxidation of methionine residues, and 
with one missed cleavage also allowed in the search parameters. Protein identification in 
the mass spectra was performed by Applied Biomics (Hayward, CA). 
 
Quantification of Band Ratios 
ImageJ64 was used to process and quantify α1 GlyR-labeled band intensity at 
approximately 100 kDa and 50 kDa, which corresponded to the loci in which monomeric 
and dimeric GlyR subunits were identified by MS. These band intensities were then 
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calculated and reported as direct ratios (100:50 kDa), and statistically significant 
differences in band ratio between the uncross-linked and cross-linked conditions were 
measured for the representative TM1-3 mutant and the wild-type using repeated-





Previous studies using cysteine substitution and alkyl thiol reagents have shown 
that I229 in TM1 and A288 in TM3 are water-accessible and play critical role in 
anesthetic action (Jenkins et al., 2001; Lobo et al., 2004a; Lobo et al., 2004b), and initial 
biochemical cross-linking studies showed evidence of cross-link formation and suggested 
I229 and A288 likely participate in a common alcohol and volatile anesthetic binding 
cavity. However, it remains uncertain whether the I229C/A288C cross-links are formed 
between residues within the same subunit (intra-subunit) or between subunits (inter-
subunit), and whether these residues are participating in common alcohol-binding cavity 
within or between GlyR subunits. Therefore, the purpose of the present study was to 
examine these possibilities (i.e. intra-subunit vs inter-subunit cross-linking) using 
cysteine mutagenesis, Xenopus oocyte electrophysiology, and immunoblotting with a 
GlyR-specific antibody. 
 The I229C/A288C double mutant and I229C/A288C/C290S triple mutant 
previously shown to form cross-links in Lobo et al. (2008) as well as the corresponding 
single mutants were each expressed in oocytes.  Glycine-induced current was measured, 
and the alcohol and volatile anesthetic effects were compared before and after cross-
linking with HgCl2, which reacts with accessible pairs of cysteines to form intermolecular 
S-Hg-S dimers when the residues are in proximity to one another and located on 
opposing faces of adjacent helices (Struthers et al., 2000; Soskine et al., 2002).  The 
glycine sensitivity of the cysteine mutants was reported (Lobo et al., 2008), and although 
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the mutations produced some degree of altered glycine sensitivity (Table1), all of the 
mutants formed functional GlyRs.   
 First, we examined whether the cross-linking of I229C in TM1 with A288C in 
TM3 alters alcohol enhancement of GlyR function. Specifically, the potentiation of 
submaximal (EC5-10) glycine-induced current by 22 mM butanol was compared before 
and after the application of the cross-linking agent HgCl2. Similar to Lobo et al. (2008), 
agonist-induced rotation of the TM domain appears to be necessary for the formation of 
cross-links in the I229C/A288C mutant, so 10 µM HgCl2 was applied in the presence of 
100 mM glycine (maximal) for these experiments. We found butanol potentiation was 
nearly abolished in both the I229C/A288C double mutant and I229C/A288C/C290S triple 
mutant following the application of HgCl2, but there was no significant effect on butanol 
potentiation in the wild-type or single mutants (Figure 2.1). 
 Next, we investigated whether the cross-linking of I229C in TM1 with A288C in 
TM3 alters volatile anesthetic enhancement of GlyR function.  Specifically, we measured 
the potentiation of submaximal (EC5-10) glycine current by 0.6 mM (2xMAC) isoflurane 
before and after the application of HgCl2.  As described above for the butanol 
experiment, HgCl2 was applied in the presence of maximal glycine. There was no effect 
of HgCl2 on the wild-type or single mutants. However, isoflurane potentiation was 
significantly decreased in both the I229C/A288C double mutant and 
I229C/A288C/C290S triple mutant (Figure 2.2). 
 In order to verify the results of HgCl2 cross-linking by an alternative method in 
preparation for the immunoblotting experiments, we tested the ability of the oxidizing  
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Receptor Glycine EC50 
(µmol/L) 
WT 180 ± 56 
I229C 110 ± 7.0 
A288C 1800 ± 190 
I229C/A288C 180 ± 37 
I229C/A288C/C290S 81 ± 45 
 
Table 1 
Glycine EC50 values for wild-type and mutant TM1-3 
glycine receptors. All values represent mean ± SEM 






Figure 2.2. Alcohol potentiation of EC5-10 glycine response in mutant TM1-3 GlyRs. As 
described in Lobo et al. (2008), 10 µM HgCl2 was applied in the presence of 100 mM 
glycine (i.e. the activated/desensitized state) to the I229C/A288C double mutant and the 
I229C/A288C/C290S triple mutant (as well as single mutant controls) and produced 
evidence of cross-linking.  The effect of 22 mM butanol was compared before and after 
10 µM HgCl2 was applied in the presence of glycine to the mutants and the wild-type. All 
values represent mean ± SEM from 4-5 oocytes. Repeated-measures t-tests were used to 




Figure 2.3. Anesthetic potentiation of EC5-10 glycine response in mutant TM1-3 GlyRs. 
As described in Lobo et al. (2008), 10 µM HgCl2 was applied in the presence of 100 mM 
glycine (i.e. the activated/desensitized state) to the I229C/A288C double mutant and the 
I229C/A288C/C290S triple mutant (as well as corresponding single mutant controls) and 
produced evidence of cross-linking. The effect of 0.6 mM isoflurane was similarly tested 
on the mutants and the wild-type before and after 10 µM HgCl2 was applied in the 
presence of glycine. All values represent mean ± SEM from 4-5 oocytes. Repeated-
measures t-tests were used to detect differences between the Pre-HgCl2 and Post-HgCl2 
conditions for each receptor. *p<0.05  
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agent, H2O2, to induce disulfide bond formation in the I229C/A288C double mutant that 
showed evidence of cross-linking. We also tested the I229C/C290S double and 
I229C/A288C/C290S triple mutants to help address the possibility that I229C in TM1 
may be cross-linking with the endogenous cysteine at position 290, instead of A288. In 
accordance with the HgCl2 experiments and iodine studies previously conducted by Lobo 
et al. (2008), cross-linking was again observed for the I229C/A288C double and the 
I229C/A288C/C290S triple mutants following the application of 0.5% H2O2, resulting in 
significantly decreased glycine-induced current. The effect was reversed by reduction 
with 10 mM DTT. However, no cross-linking was observed for the wild-type, I229C 
single mutant, or I229C/C290S double mutant (Figure 2.4). The I229C/A288C/C290S 
triple mutant appears to form cross-links in an almost identical manner to that of the 
I229C/A288C double mutant, suggesting that the endogenous cysteine at position 290 is 
not responsible for the effects observed and the cross-links are forming between I229 in 
TM1 and A288 in TM3. Therefore, the I229C/A288C/C290S triple mutant was not 
included in the remainder of this study, and we focused on the I229C/A288C double 
mutant in order to elucidate whether the cross-links formed between I229 and A288 are 
occurring within the same subunit (intra-subunit) or between subunits (inter-subunit), and 
whether these residues are participating in a common alcohol-binding cavity within or 
between GlyR subunits. 
 To assess these possibilities further, we extracted protein from oocytes injected 
with wild-type GlyRs or the I229C/A288C double mutant from above and then used 
immunoblotting with a GlyR-specific antibody (Figure 2.5A and B). We subsequently  
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Figure 2.4. Effects of oxidation with H2O2 and reduction with DTT on GlyRs. 0.5% H2O2 
was applied in the presence of 100 mM glycine (i.e. the activated/desensitized state), 
which produced evidence of cross-linking in the I299C/A288C and I229C/A288C/C290S 
mutants only. This effect was reversed by 10 mM DTT. All values represent mean ± 
SEM from 4-5 oocytes. One-way ANOVA with Tukey’s post-test was used to detect 
differences between the Pre- H2O2, Post- H2O2, and Post-DTT conditions for each 
receptor. *p<0.05  
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verified protein identity by mass spectrometry (MALDI-TOF/TOF) (Table 2). The 
differences in 100:50 kDa band ratios were compared between uncross-linked and cross-
linked conditions for the wild-type and I229C/A288C double mutant. Wild-type GlyR 
subunits measure about 50 kDa under ordinary conditions. Therefore, we hypothesized 
that if cross-linking occurred between two adjacent subunits, then we would observe an 
increase in the presence of GlyR-labeled 100 kDa band, and an increase in the ratio of 
100:50 kDa bands. Alternatively, we expected no change for cross-linking within a 
subunit. For the I229C/288C mutant, we found a significant increase in the 100:50 kDa 
band ratio (Figure 2.6), which suggests that TM1-3 may participate in an 
alcohol/anesthetic binding cavity between GlyR subunits. There was not a significant 
difference in the 100:50 kDa band ratio between the uncross-linked or cross-linked 





Figure 2.5. Immunoblot for WT and mutant TM1-3 GlyRs. A) Immunblotting reveals a 
dominant 50 kD band, the anticipated molecular weight of a GlyR subunit, with 
increasing concentrations of wild-type GlyR protein, unlike in the lanes loaded with 
samples comprised of uninjected (uninj) oocytes, which only showed faint evidence of 
non-specific labeling at lower molecular weight. B) 100 kD and 50 kD α1 GlyR-labeled 
bands in the wild-type and I229C/A288C mutant in the uncross-linked vs cross-linked 






























GLRA1 100-105 59 
GLRA1 100 59 
GLRA1 50-55 87 
GLRA1 48-50 78 
 
Table 2 
Protein Identification of Wild-Type GlyR. All values are from a 








Figure 2.6. Quantification of Band Ratios for WT and TM1-3 mutant GlyRs. The100:50 
kDa band ratio increased for the I229C/A288C double mutant when cross-linked, 
however there was no significant  increase for the wild-type. Immunoblot images were 
processed using ImageJ64 software, and the band intensity was taken and reported as a 
direct ratio. 0.5% H2O2 was applied by bath perfusion as previously described 
(McCracken et al., 2010).  Independent t-tests were used to detect differences between 




Our findings suggest that the formation of a cross-link between residue 288 in 
TM3 and residue I229 in TM1 reduces the ability of alcohol and volatile anesthetics to 
bind and produce their effects at an inter-subunit cavity in the GlyR. These results are in 
accordance with similar studies in the GABAAR. For example, Bali et al. (2009) 
suggested that the homologous residue to I229 in TM1 of the GABAAR is oriented 
toward the subunit interface such that it is able to form cross-links with TM3 of an 
adjacent subunit, and photoaffinity labeling studies have suggested that multiple classes 
of general anesthetics may act at this inter-subunit site (Zhong et al., 2008; Stewart et al., 
2008; Li et al., 2010). Moreover, crystallographic studies using an ethanol-sensitized 
GLIC mutant co-crystallized with ethanol, bromoethanol and bromoform provide 
additional support for an inter-subunit binding cavity (Sauguet et al., 2013).  
These results differ, at least in part, from the recent x-ray structure of the volatile 
anesthetic desflurane bound at an intra-subunit cavity in the bacterial homologue GLIC 
(Nury et al., 2011) and suggest that anesthetic interaction with GLIC may involve more 
than a simple binding cavity either between or within subunits. Similarly, Borghese et al. 
(2014) reported evidence for an intra-subunit alcohol/anesthetic binding cavity in the 
GABAAR β2 subunit using biochemical cross-linking and alkyl thiol labeling techniques, 
which specifically revealed that residue N265 in TM2 (homologous to S267 in TM2 of 
the α1 GlyR) could form cross-links with other β2 residues in both TM1 and TM3 of the 
same subunit. This appears to be consistent with earlier studies in the α1 GlyR in which 
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the formation of a cross-link between A288 in TM3 and 267 in TM2 significantly 
reduced alcohol or volatile anesthetic effects (Lobo et al., 2004b). However, in 
accordance with our findings here and the work mentioned above by Bali et al. (2009), 
Borghese et al. (2014) also found evidence for inter-subunit cross-linking between the 
homologous TM1 residue in the GABAAR α1 subunit (L232) and the TM3 residue in β2, 
but one helical turn below the site homologous to A288 in the GlyR. This further suggests 
that, in addition to GLIC, alcohol and anesthetic interaction with these critical residues in 
the mammalian ion channels also involves additional complexity beyond exclusive 
binding either at inter-subunit or intra-subunit site. 
 Additionally, the results from our oxidation experiment in the present study 
corroborate earlier cross-linking studies in the GlyR that initially investigated the 
proximity and orientation of residue A288 in TM3 with residues in TM1, particularly the 
critical alcohol and anesthetic residue at I229. Previously, Lobo et al. (2008) used iodine 
and HgCl2 to independently test for cross-linking in a number of GlyR TM1 and TM3 
double cysteine mutants. Of note, evidence of cross-linking was reported in the 
I229C/A288C and I229C/A288C/C290S double and triple mutants, which was reversible 
with DTT following application of either HgCl2 or iodine. This is in agreement with our 
present findings using H2O2 and HgCl2, which we validated with immunoblotting. Based 
on earlier homology modeling used in Lobo et al. (2008), it was suggested that, perhaps, 
cross-linking was occurring between TM1 and TM3 of the same subunit. At the time, the 
4Å resolution structure of the Torpedo nAChR was commonly used as a template to 
model members of the Cys-loop family of ion channels, including the GlyR. However, 
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the lack of some conserved residues created sequence alignment challenges between the 
nAChR and GlyR, especially in the TM2-3 loop and TM3 region, which resulted in 
added uncertainty about the orientation and proximity of residues in TM3. The 
emergence of x-ray structures for the prokaryotic homologues ELIC and GLIC as well as 
the invertebrate GluCl have since provided greater insight and helped to clarify some 
these alignment discrepancies. Nevertheless, the combination of the present study and 
Lobo et al. (2008) demonstrate that the earlier homology models based on the Torpedo 
nAChR still proved valuable in helping to identify critical residues for further 
experimental testing in heterologous expression systems and yielded useful predictions 
and hypotheses about the location of putative alcohol/anesthetic binding pockets with the 
GlyR.  
When considering the accumulating experimental evidence from studies in the 
GlyR as well as studies of the closely related GABAAR, it becomes increasingly difficult 
to explain the inter-subunit cross-linking of TM3 with TM1 in an adjacent subunit and 
intra-subunit cross-linking with TM2 or TM4 of the same subunit (Lobo et al., 2004b; 
Bali et al., 2009; McCracken et al., 2010; Borghese et al., 2014) without a substantial 
degree of flexibility or motion, especially in the upper portion of TM3. Figure 2.7 
(adapted from Bertaccini et al., 2010) illustrates the predicted orientation of I229 in TM1 
and A288 in TM3 of adjacent GlyR subunits with an anesthetic molecule drawn at the 
subunit cleft, and also notes the proximity of TM4 residues which have been previously 
shown to cross-link with A288 in TM3.  Based on hGlyR-α1 TM NMR spectroscopy 
studies, Mowrey et al. (2013) reported a highly dynamic segment in the TM region 
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Figure 2.7 Overhead view of critical GlyR TM sites for anesthetic action. Adjacent 
subunits are distinguished by color, gold and green, etc. A hypothetical anesthetic 
molecule is drawn in the proposed inter-subunit site at the subunit cleft. This homology 
model is based on the prokaryotic homologue GLIC (adapted from Bertaccini et al., 
2010).   
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 encompassing S267 in TM2 through approximately A288 in TM3. This may help to 
explain the ability of A288 to cross-link with I229 in TM1 across the subunit cleft, and 
alternatively, also potentially cross-link in the opposite direction with 267 in TM2 or the 
residues in TM4 (Y406, W407, I409, Y410). This seems plausible given that a number of 
these mutants, including I229 in TM1 and Y406 and I409 in TM4, require the co-
application of glycine in the presence of the cross-linking/oxidizing agent.  It has been 
suggested that the application of agonist creates a wringing motion in the extracellular 
domain due to ligand binding and may result in downstream rotation in the TM segments 
(Unwin, 2005).  Another, similar example of motion has been described in the GluCl-
ivermectin model (Yoluk et al., 2013). 
 In summary, we demonstrate that cross-linking between I229 in TM1 and A288 in 
TM3 reduces the ability of alcohol or anesthetic to enhance GlyR function. In addition, 
we provide evidence using immunoblotting that these cross-links are formed between 
adjacent subunits, suggesting that TM1 and TM3 likely participate in an inter-subunit 




CHAPTER III: Evidence for the Participation of Transmembrane 
Segments 3 and 4 in a Common Intra-subunit Alcohol and Volatile 
Anesthetic Binding Cavity in the Glycine Receptor 
 
INTRODUCTION 
 GlyRs are members of the Cys-loop family of ligand-gated ion channels, which 
includes the nicotinic acetylcholine receptor (nAChR), the serotonin 3 receptor (5-HT3R), 
and γ-aminobutyric acid type A (GABAAR). GlyRs not only mediate the majority of 
inhibitory neurotransmission in the brain stem and spinal cord (Legendre, 2001), but they 
are also expressed in other brain regions including the olfactory, hippocampus, nucleus 
accumbens (van den Pol and Gorces, 1988; Fatima-Shad and Barry, 1993; Molander and 
Soderpalm, 2005; Baer et al., 2009; Jonsson et al., 2012) and cerebellum (Takahashi et 
al., 1992). Although a GlyR crystal structure has not yet been solved, medium to high 
resolution structures exist for related ligand-gated ion channel motifs, including the 
acetylcholine binding protein (AChBP) (Brecj et al., 2001; Celie et al., 2004) and the 
Torpedo nAChR (Unwin, 2005). Additionally, the x-ray structures have been solved for 
two prokaryotic homologues, Erwinia chrysanthemi (ELIC) and Gloebacter violaceus 
(GLIC) (Hilf and Dutzler, 2008; Hilf and Dutlzer, 2009; Bocquet et al., 2009), and the 
invertebrate Caenorhabditis elegans glutamate-gated chloride channel (GluCl) (Hibbs and 
Gouaux, 2011). Most recently, Mowrey et al. (2013) usednuclear magnetic resonance 
(NMR) spectroscopy and electron microroscopy to produce specific structural 
information from the expressed hGlyR-α1 TM domain. This lower resolution structural 
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information, as well as these high-resolution x-ray structures, combined with 
experimental data from studies in heterologous expression systems, has provided insight 
into GlyR structure. 
 Functional GlyRs receptors are composed of five homologous subunits positioned 
around a central chloride channel, with the structure of each subunit consisting of an 
extracellular N-terminal domain, a transmembrane domain with four alpha helical 
segments (TM1, TM2, TM3, and TM4), an intracellular loop between TM3 and TM4, 
and an extracellular C-terminal domain. Four GlyR α subunits (1-4) and a single β 
subunit have been identified (Grenningloh et al., 1990; Harvey et al., 2000; Harvey et al., 
2004). There is 80-90% sequence identity among the α subunits and approximately 50% 
identity among the β subunit and the α subunits, which can assemble to form either 
homomeric α receptors or heteromeric αβ receptors (Lynch, 2004). 
 It is well established that alcohols and volatile anesthetics likely share common 
sites of action in the GlyR (Mihic et al., 1997; Beckstead et al., 2001) and serve as 
positive allosteric modulators of GlyR function (Harrison et al., 1993; Mascia et al., 
1996). Moreover, critical amino acid residues for alcohol and anesthetic enhancement of 
the α1 GlyR have been identified in TM1-3 (I229, S267, and A288 in TM1, 2, and 3, 
respectively) (Mihic et al., 1997; Lobo et al., 2004a).  Although the role of TM4 in 
alcohol and anesthetic action at the GlyR has not been as extensively examined as TM1-
3, studies using site-directed mutagenesis and alkyl thiol reagents suggest that TM4 
residues, along with the implicated residues in TM1-3, may face into a water-filled, 
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alcohol/anesthetic-binding cavity within the TM domain of each subunit (i.e. an intra-
subunit binding pocket) (Mascia et al., 2000; Jenkins et al., 2001; Lobo et al., 2004a; 
Lobo et al., 2006).  
 In accordance, early homology modeling based on the nAChR predicted that 
A288 of TM3 could face into an intra-subunit helical bundle (Ernst et al., 2005; Young et 
al., 2008), which is consistent with experimental biochemical cross-linking data 
demonstrating the ability of A288 in TM3 to form cross-links with I229 in TM1 and/or 
S267 in TM2 (Lobo et al., 2004b; Lobo et al., 2008). More recent studies using cysteine 
mutagenesis and oxidizing agents have begun to investigate the proximity of A288 in 
TM3 to residues in TM4 and provide evidence that Y406, W407, I409, and Y410 in TM4 
are able to form cross-links with A288 in TM3, which supports the assignment of these 
TM4 residues as intra-subunit facing (McCracken et al., 2010; Bertacini et al., 2010). In 
addition, recent x-ray structures of anesthetics bound to the bacterial homologue GLIC 
and photolabeling of GABAA receptors further support action at an intra-subunit cavity 
(Nury et al., 2011) 
 Alternatively, others have proposed the presence of an inter-subunit alcohol and 
general anesthetic binding pocket at the subunit interface. Specifically, Bali et al. (2009) 
suggested that the homologous residue to A288 in TM3 of the GABAA receptor is 
oriented toward the subunit interface such that it is able to form cross-links with TM1 
residues of an adjacent subunit, and photoaffinity labeling studies have suggested that 
multiple classes of general anesthetics may act at this inter-subunit site (Zhong et al., 
2008; Stewart et al., 2008; Li et al., 2010). This inter-subunit hypothesis has been 
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recently supported by crystallography work paired with functional studies in GLIC, 
which determined and compared the crystal structures of receptors in the presence and 
absence of ethanol and bromoethanol (Sauguet et al., 2013). 
 Lastly, a third “multisite” hypothesis has emerged suggesting that perhaps 
alcohols and anesthetics may, in fact, bind and act at both intra-subunit and inter-subunit 
sites within GlyR proteins. This hypothesis has been generated largely from mutagenesis 
studies in the GLIC and GluCl homologues, molecular simulations, and newer homology 
modeling (Howard et al. 2011; Murail et al., 2012; Yoluk et al., 2013). Recent cross-
linking studies in the mammalian GABAA receptor also provide additional support for the 
“multisite” hypothesis, but suggest that the effects may be influenced by receptor type 
and state as well as differentially affected by alcohols and anesthetics (Borghese et al., 
2013). 
 However in the absence of a crystal structure for either the GlyR or the GABAAR, 
the orientation of these residues, and ultimately a putative alcohol and volatile anesthetic 
binding pocket, remains uncertain. Therefore, the goal of the present study was to 
investigate the possibility that A288 in TM3 participates in cross-linking with intra-
subunit facing residues in TM4.  To do so, we examined whether cross-linking A288 with 
each of the intra-subunit facing residues in TM4 (Y406, W407, I409, and Y410) altered 
alcohol or volatile anesthetic enhancement of α1 GlyR function. 
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MATERIALS AND METHODS 
Materials 
 All chemical reagents and buffer constituents were purchased from Sigma-
Aldrich (St. Louis, MO). Adult female Xenopus laevis frogs were obtained from Nasco 
(Ft. Atkinson, WI). 
 
Site-directed Mutagenesis 
 Point mutations in the human glycine receptor α1 subunit (subcloned in the 
pBKCMV N/B-200 vector) were achieved using a QuickChange site-directed 
mutagenesis kit (Stratagene, La Jolla, CA). Specifically, the A288C, Y406C, W407C, 
I408C, I409C, and Y410C single mutants were constructed. Additionally, the 
A288C/Y406C, A288C/W407C, A288C/I409C, and A288C/Y410C double mutants were 
made. All point mutations were verified by DNA sequencing in the core facility at the 
University of Texas at Austin. 
 
Oocyte Isolation and cDNA Injection 
 Portions of ovary were surgically extracted from adult female Xenopus laevis 
frogs, and mature oocytes were manually isolated. Following isolation, ooctytes were 
treated in 0.5 mg/ml collagenase (type IA) and subsequently injected into the nucleus 
with 30 nl of nuclease-free water and cDNA (1.5 ng/30 nl) encoding either wild-type or 
mutant human α1 glycine receptors. Injected oocytes were incubated at 13°C in sterile 
modified Barth’s solution (MBS) (88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO3, 19 mM 
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HEPES, 0.82 mM MgSO4, 0.33 mM Ca(NO3)2, 0.91 mM CaCl2, 10,000 units/liter 
penicillin, 50 mg/liter gentamicin, 90 mg/liter theophylline, 220 mg/liter sodium 
pyruvate, pH 7.5) for 1-7 days. 
 
Electrophysiological Recording 
 Two-electrode voltage clamp electrophysiology was used to measure glycine-
induced current from oocytes 1-7 days following injection with cDNAs. Oocytes were 
place in a rectangular chamber (~ 100 µl) and continuously perfused at a rate of 2 ml/min 
with MBS at 13°C. A -70 mV holding potential was achieved using to two glass 
electrodes containing 3 M KCl and a Warner Instrument oocyte clamp (Hamden, CT). 
All solutions were prepared immediately before use and applied by bath perfusion. 
A glycine EC5-10 (the concentration that produced 5-10% of the maximal 
response) was determined for each oocyte after application of the maximal glycine 
concentration and served as the test glycine concentration. All test glycine concentrations 
were 30 s and were followed by a 5 min washout. Oocytes received two consecutive 
applications of the test glycine concentration to ensure that responses were stable. 
Alcohols or anesthetics were pre-applied for 1 min alone and then co-applied with 
glycine for 30 s. All drug applications were immediately followed by a 10 min washout. 
The test glycine concentration was applied again, and the percent potentiation of the 
glycine-induced current by the alcohol or anesthetic was calculated for each oocyte. 10 
µM HgCl2 was applied for 1 min (in the absence of glycine for the A288C/W407C and 
A288C/Y410C mutants and in the presence of 100 mM glycine for the A288C/Y406C 
 44 
and A288C/I409C mutants as previously published in McCracken et al., 2010) and 
followed by a 15 min washout. Afterward, the maximal glycine concentration was re-
applied and the test concentration (EC5-10) was recalculated. The potentiation of glycine-
induced current by the alcohol or anesthetic was then measured again as described above 
. This protocol was used to test the effects, in both the resting and open/desensitized 
states, of 22 mM butanol and 0.6 mM isoflurane, which corresponds to approximately 
two times the minimal alveolar concentration (MAC) for these drugs. 
Data Analysis. For each receptor tested, repeated-measures t-tests were used to 
detect differences between pre-HgCl2 and post-HgCl2 conditions (i.e. before and after 
cross-linking). GraphPad PRISM software (San Diego, CA) was used for all analyses, 
and statistical significance was determined at p < 0.05. 
 
Protein Extraction 
Individual oocytes were manually isolated and injected with 1.5 ng/nl cDNA as 
described above. Injected oocytes were incubated for 5-7 days at 13°C. Groups of 25 
oocytes were pooled for each condition. Those included in the cross-linked condition 
were treated with 0.5 % H2O2 by bath perfusion as described in McCracken et al. 2010 
and as described for the HgCl2 application above in the electrophysiology experiments. 
Following a 15 min washout, oocytes were homogenized in 1 mL of Wash Buffer (0.1M 
EDTA, pH 7.5; 0.1 M EGTA, pH 7.5; 2M NaCl; 0.1M NaH2PO4, pH 7.5) with protease 
inhibitors (5 mM benzamidine; 15 mM iodoacetamide), and then centrifuged at 4°C for 
30 min at 13500 rpm. The supernatant was removed, and 250 µL of Extraction Buffer 
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(wash buffer described above + 2% Triton + 5 mM benzamidine + 15 mM 
iodoacetamide) was added. The pellet was resuspended, rotated at 4°C for 2 hrs, and then 
centrifuged at 4°C for 30 min at 13500 rpm. The supernatant was removed and saved as 
the protein extract. Similar protein extract protocols using Xenopus oocytes have been 
described previously by Bali et al. (2009).  
 
Immunoblotting 
Equal amounts of soluble proteins extracted from oocytes were resolved by SDS-
PAGE and electrotransferred to polyvinylidene fluoride membrane in a buffer containing 
25 mM Tris, 192 mM glycine, 0.1% (w/v) SDS, and 20% (v/v) methanol for 1 h at 18 V. 
Membranes were briefly rinsed in a buffer containing 10 mM Tris HCl (pH 8.0), 150 mM 
NaCl and 0.01% (v/v) Tween-20 (TBS-T), and then incubated at room temperature for 1 
h in TBS-T containing 5% (w/v) skimmed milk powder to block non-specific binding of 
antibodies. Incubation of membranes with specific primary antibody for GlyR α1 
(AbCam, Cambridge, England) was performed in TBS-T containing 1% skimmed milk 
and 1% BSA powders (w/v) for 2 h at room temperature, followed by three 10 min 
washes with TBS-T alone. Membranes were then incubated for 1 h at room temperature 
with an appropriate secondary antibody conjugated to horseradish peroxidase (HRP), 
diluted in TBS-T /1% (w/v) skimmed milk and BSA powders, followed by three 5 min 
washes with TBS-T. After the final wash, blots were immediately developed by applying 
the Enhanced Chemi-Luminescence (ECL) reagent (Pierce Chemical Co., Rockford, IL) 
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for 2 min, and then a Kodak Image Station 2000MM (Eastman Kodak, Rochester, NY) 
was used to acquire images. 
 
Protein Identification by Mass Spectrometry 
Gel bands of interest were excised and washed 3 times then digested in-gel with 
modified porcine trypsin protease (Promega, Fitchburg, WI). The digested tryptic 
peptides were desalted using a Zip-tip C18 (Millipore, Billerica, MA). Peptides were 
eluted from the Zip-tip with 0.5μL of matrix solution (α-cyano-4-hydroxycinnamic acid, 
5 mg/mL in 50% acetonitrile, 0.1% trifluoroacetic acid, 25mM ammonium bicarbonate) 
and spotted on a MALDI plate. 
Mass Spectrometry. MALDI-TOF MS and TOF/TOF tandem MS/MS were 
performed on AB SCIEX TOF/TOF™ 5800 System (AB SCIEX). MALDI-TOF mass 
spectra were acquired in reflectron positive ion mode, averaging 4000 laser shots per 
spectrum. TOF/TOF tandem MS fragmentation spectra were acquired for each sample, 
averaging 4000 laser shots per fragmentation spectrum on each of the 7-10 most 
abundant ions present in each sample (excluding trypsin autolytic peptides and other 
known background ions). 
Database search. Both the resulting peptide mass and the associated fragmentation 
spectra were submitted to GPS Explorer workstation equipped with MASCOT search 
engine (Matrix Science, Boston, MA) to search the Swiss-Prot database. Searches were 
performed without constraining protein molecular weight or isoelectric point, with 
variable carbamidomethylation of cysteine and oxidation of methionine residues, and 
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with one missed cleavage also allowed in the search parameters. Protein identification in 
the mass spectra was performed by Applied Biomics (Hayward, CA). 
 
Quantification of Band Ratios 
ImageJ64 was used to process and quantify α1 GlyR-labeled band intensity at 
approximately 100 kDa and 50 kDa, which corresponded to the loci in which monomeric 
and dimeric GlyR subunits were identified by MS. These band intensities were then 
calculated and reported as direct ratios (100:50 kDa), and statistically significant 
differences in band ratio between the uncross-linked and cross-linked conditions were 
measured for the representative TM3-4 mutant and the wild-type using repeated-
measures t-tests, p < 0.05. 
 
Molecular Modeling 
A homology model of homo-pentameric GlyRa1 was built by threading the primary GlyR 
sequence onto the X-ray structure of the eukaryotic glutamate-gated chloride channel 
(GluCl, PDB ID 3RHW). The cytoplasmic TM3-4 loop was trimmed to match the length 
of the GluCl template in that region. The modeling and subsequent refinement were 
essentially as described previously (McCracken et al., 2010). In that the GluCl structure 
is eukaryotic and, as opposed to our previous models based on GLIC (PDB ID 3EAM), is 
ligand-gated in the ligand-binding domain rather than by protons. In addition, the 
sequence identity and similarity between GlyR and GluCl is higher that with GLIC 
(McCracken, et al., 2010). In contrast to the alignment of GlyR with nAChR (PDB ID 
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2BG9), there are no gaps in the alignment in the TM2-3 loop (Ernst, 2005) and the 
similarity of residues in TM4 is evident. The refined model was used to mutate residues 





Previous studies using cysteine substitution and alkyl thiol reagents have shown 
that residues in TM4 are water-accessible and suggest that these residues, along with 
others from TM1-3, including A288, may contribute to a water-filled, intra-subunit drug 
binding pocket (Jenkins et al., 2001; Lobo et al., 2006; Lobo et al., 2008). In addition, 
studies using cysteine mutagenesis and cross-linking agents have begun to investigate the 
proximity of A288 in TM3 to residues in TM4 and provide evidence that Y406, W407, 
I409, and Y410 in TM4 are able to form cross-links with A288 in TM3, which supports 
the assignment of these residues as intra-subunit facing (McCracken et al., 2010). 
Therefore, the purpose of the present study was to determine whether cross-linking 
A288C in TM3 with intra-subunit facing residues in TM4 alters alcohol or volatile 
anesthetic enhancement of α1 GlyR function.    
 The four double cysteine mutants (A288C/Y406C, A288C/W407C, 
A288C/I409C, and A288C/Y410C) previously shown to form cross-links in McCracken 
et al. (2010) as well as the corresponding single mutants were each expressed in Xenopus 
laevis oocytes. Two-electrode voltage clamp electrophysiology was used to measure 
glycine-induced current, and alcohol and volatile anesthetic effects were measured before 
and after the application of the cross-linking agent HgCl2, which reacts with accessible 
pairs of cysteines to form intermolecular S-Hg-S dimers when the residues are in 
proximity to one another and located on opposing faces of adjacent helices (Struthers et 
al., 2000; Soskine et al., 2002). The glycine concentration-responses of the single and 
double cysteine mutants were reported (Lobo et al., 2006; McCracken et al., 2010), and 
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although the mutations result in some degree of altered glycine sensitivity (Table 3.1), all 
of the mutants formed functional GlyRs.   
First, we investigated whether the cross-linking of A288C in TM3 with intra-
subunit facing residues in TM4 alters alcohol enhancement of GlyR function.  We 
measured the potentiation of submaximal (EC5-10) glycine-induced current by 22 mM 
butanol before and after application of the cross-linking agent HgCl2.  As described in 
McCracken et al. (2010), 10 µM HgCl2 was applied to the A288C/W407C and 
A288C/Y410C double mutants and corresponding single mutants in the resting state 
(absence of glycine) (Figure 3.1A). However, agonist-induced rotation of TM3 is 
necessary for the formation of cross-links in the A288C/Y406C and A288C/I409C, so for 
these double mutants and the corresponding single mutants, 10 µM HgCl2 was applied in 
the presence of maximal glycine (Figure 3.1B). We found that while the application of 
HgCl2 had no significant effect on butanol modulation of submaximal glycine response in 
the wild-type or single mutants, butanol modulation was significantly decreased in all 
four double cysteine mutants following the application of HgCl2 (Figure 3.1A and B). 
 Similarly, we examined whether the cross-linking of A288C in TM3 with intra-
subunit facing residues in TM4 alters volatile anesthetic enhancement of GlyR function.  
We compared the potentiation of submaximal (EC5-10) glycine current by 0.6 mM 
isoflurane before and after the application of HgCl2. As described above, HgCl2 was 
applied to the A288C/W407C and A288C/Y410C double mutants and corresponding 
single mutants in the resting state (absence of glycine), whereas HgCl2 was applied in the 
presence of maximal glycine for the A288C/Y406C and A288C/I409C double mutants  
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Receptor Glycine EC50 
(mM) 
WT 0.3 ± 0.1 
A288C 2.8 ± 0.8 
Y406C 3.8 ± 0.1 
W407C 0.7 ± 0.1 
I409C 0.4 ± 0.1 
Y410C 0.5 ± 0.1 
A288C/Y406C 6.5 ± 1.5 
A288C/W407C 6.0 ± 0.2 
A288C/I409C 4.4 ± 2.8 
A288C/Y410C 26 ± 1.6 
 
Table 3 
Glycine EC50 values for wild-type and 
mutant TM3-4 glycine receptors. All values 
represent mean ± SEM from 4-11 oocytes. 




Figure 3.1. Alcohol potentiation of EC5-10 glycine response in TM3-4 mutant GlyRs. A) 
As described in McCracken et al. (2010), 10 µM HgCl2 was applied to the 
A288C/W407C and A288C/Y410C double mutants in the absence of glycine (i.e. the 
resting state) and produced evidence of cross-linking.  Accordingly, the butanol effect on 
these double mutants and the corresponding single mutants was compared before and 
after 10 µM HgCl2 was applied alone.  B) However for the A288C/Y406C and 
A288C/I409C double mutants, cross-linking was only observed when 10 µM HgCl2 was 
applied in the presence of 100 mM glycine (i.e. the activated/desensitized state), so the 
these double mutants and the corresponding single mutants were tested under similar 
conditions.  All values represent mean ± SEM from 4-5 oocytes. Repeated-measures t-
tests were used to detect differences between the Pre-HgCl2 and Post-HgCl2 conditions for 




and corresponding single mutants. Following the application of HgCl2, isoflurane 
potentiation was nearly abolished in all four of the double cysteine mutants, but not in the 
wild-type or single mutants (Figure 3.2A and B). 
Next, we addressed the possibility that the diminished butanol and isoflurane 
effects in the double mutants following HgCl2 application was due to Hg2+ binding to 
each of the substituted cysteines and forming S-Hg-Cl bonds, rather forming a cross-link 
between TM3 and TM4 and reducing the ability of butanol or isoflurane to bind and 
produce an effect at an intra-subunit cavity within in the TM domain of the GlyR. 
Although this possibility is unlikely given that the butanol and isoflurane effects were not 
significantly altered in the single mutants, we measured butanol and isoflurane 
modulation in the A288C/Y406C and A288C/I409C mutants when HgCl2 was applied in 
the absence of glycine, which has been previously shown not to produce functional 
effects or, presumably, cross-links. Accordingly, we found that in the A288C/Y406C 
mutant, the potentiation of EC5-10 glycine response by 22 mM butanol was not 
significantly altered following the application of HgCl2 in the absence of glycine. In 
addition, the application of HgCl2 alone did not significantly alter potentiation by 0.6 mM 
isoflurane. Similarly, HgCl2 alone had no significant effect on butanol or isoflurane 
modulation of the A288C/I409C double mutant (data not shown). Taken together, our 
findings suggest that the formation of a cross-link between A288 in TM3 and residues in 
TM4 reduces the ability of alcohols and volatile anesthetics to bind and produce an effect 
and further supports the participation of these residues in a common binding cavity. 




Figure 3.2. Anesthetic potentiation of EC5-10 glycine response in mutant TM3-4 GlyRs. 
A) In accordance with the butanol experiments, 10 µM HgCl2 was applied to the 
A288C/W407C and A288C/Y410C double mutants and corresponding single mutants in 
the resting state (absence of glycine), and the potentiation of submaximal glycine 
responses by 0.6 mM isoflurane was compared before and afterward. B) For the 
A288C/Y406C and A288C/I409C double mutants and corresponding single mutants, 
HgCl2 was applied in the activated/desensitized state (presence of 100 mM glycine). All 
values represent mean ± SEM from 4-5 oocytes. Repeated-measures t-tests were used to 
detect differences between the Pre-HgCl2 and Post-HgCl2 conditions for each receptor. 






within the same subunit (intra-subunit) or between subunits (inter-subunit), and 
ultimately whether these residues are participating in common alcohol-binding cavity 
within or between GlyR subunits.  
We used the homology model of GlyR with the residues of interest substituted 
with cysteine to determine potential sites for cross-linking (Figure 3.3). Distances 
between S-S with cysteines substituted at I229 (TM1), S267 (TM2), A288 (TM3), and 
Y406 (TM4) in two adjacent subunits ranged from about 7 to 12 Angstroms. An ideal S-S 
disulfide bond is approximately 2 Angstroms. The use of HgCl2 to form an S-Hg-S bond 
extends that final bond distance to approximately 5 Angstroms. Obviously, some rotation 
or bending of the helical segments would be required to accommodate the experimental 
cross-linking results. 
To further investigate these possibilities, we extracted GlyR protein from oocytes 
injected with wild-type GlyRs or a representative double cysteine TM3-4 mutant from 
above (A288C/Y410C), which has shown evidence of cross-link formation using either 
HgCl2 or H2O2 (McCracken et al., 2010). We then used immunoblotting with a GlyR-
specific antibody (Figure 3.3) and verified protein identification by mass spectrometry 
(MALDI-TOF/TOF) (Table 3.2). The differences in 100:50 kDa band ratios were 
quantified and compared between uncross-linked and cross-linked conditions for the 
representative TM3-4 mutant and the wild-type. Wild-type GlyR subunits typically 
measure about 50 kDa. Therefore, we hypothesized that if cross-linking occurred 




Figure 3.3. Homology Model of 3D structure of portions of GlyR TM1-4. Based on the 
invertebrate Caenorhabditis elegans glutamate-gated chloride channel (GluCl), as 
described in Methods, distances are between S-S with cysteines substituted at I229 
(TM1), S267 (TM2), A288 (TM3), and Y406 (TM4) in two adjacent subunits (red and 
blue). An ideal S-S disulfide bond is theoretically about 2 Å, however the use of HgCl2 to 
form an S-Hg-S bond extends that final bond distance to approximately 5 Å. The 
distances between S-S with cysteines substituted at the respective positions noted above 




GlyR-labeled 100 kDa band, and an increase in the ratio of 100:50 kDa bands. 
Conversely, we expected no change for cross-linking within a subunit. We did not find 
any significant differences in the 100:50 kDa band ratios between the uncross-linked or 
cross-linked conditions for either the TM3-4 mutant or the wild-type (3.4). This is 
consistent with previous homology modeling (Bertaccini et al., 2005; Unwin et al., 2005) 
and biochemical cross-linking studies suggesting that the TM4 residues of interest: Y406, 
W407, I409, and Y410 form intra-subunit cross-links with A288 of TM3 from the same 
subunit (McCracken et al., 2010) and provides evidence that these residues may 





Figure 3.4. Immunoblot for WT and mutant TM3-4 GlyRs. 100 kDa and 50 kDa α1 
GlyR-labeled bands in the wild-type and A288C/Y410C mutant in the uncross-linked vs 
cross-linked (+H2O2) conditions. 0.5% H2O2 was applied by bath perfusion as previously 












 Molecular Weight 
(kDa) 
Protein Score C.I. 
% 
GLRA1 100-105 57 
GLRA1 100 60 
GLRA1 50-55 89 
GLRA1 48-50 78 
 
Table 4 
Protein Identification of Mutant TM-3-4 Glycine Receptor. All 
values are from a representative uncross-linked A288C/Y410C 







Figure 3.5. Quantification of Band Ratios for WT and mutant TM3-4 GlyRs. The100:50 
kDa band ratio did not increase for the A288C/Y410C double mutant or the wild-type 
when cross-linked. Immunoblot images were processed using ImageJ64 software, and the 
band intensity was taken and reported as a direct ratio. 0.5% H2O2 was applied by bath 
perfusion as previously described (McCracken et al., 2010). All values represent mean ± 
SEM. Repeated-measures t-tests were used to detect differences between the uncross-





Our findings suggest that the formation of a cross-link between residue 288 in 
TM3 and residues Y406, W407, I409, and Y410 in TM4 reduces the ability of alcohol 
and volatile anesthetics to bind and produce their effects at an intra-subunit cavity in the 
GlyR. Although the crystal structure of the glycine receptor has not been solved, our 
results are consistent with the recent x-ray structure of desflurane bound at an intra-
subunit cavity in the bacterial homologue GLIC (Nury et al., 2011). More recently, 
photolabeling studies demonstrated the competitive binding of Propofol and AziPm at 
residues corresponding to the intra-subunit pocket identified in the GLIC crystal structure 
(Jayakar et al. 2013; Chiara et al., 2014), which further supports an intra-subunit site of 
action for anesthetics. However, the interaction of anesthetics and alcohols with GLIC, 
and the other ligand-gated ion channels, may involve more than a single pocket bounded 
by the four TM regions. The high-resolution structure of GLIC with desflurane and 
propofol shows a "linking tunnel," which connects inter- and intra-subunit cavities (Nury 
et al., 2011). 
The position of A288C in (Figure 3.3) is facing more into the inter-subunit space 
than toward the intra-subunit cavity. The model shows that the distances between A288C 
in TM3 of one subunit and residues in TM4 of the adjacent subunit are so great that the 
receptor would be considerably distorted by the cross-linking, and presumably, rendered 
non-functional. A more likely possibility is that the two helical turns at the extracellular 
end of TM3 are flexible. A somewhat extreme example is a “spring model” used by 
Otero-Cruz et al. (2007) to explain the effect of substitutions in TM3 of in the related 
 62 
nAChR. We previously considered the effect of a 100 degree rotation of TM3 during the 
opening transition to explain experimental cross-linking of TM3 with residues in TM4 
(McCracken et al., 2010). Currently, there are many other examples of experimental 
evidence for specific motion of TM3 or a more global motion within the subunit that 
changes the accessibility of reagents to the intra-subunit cavity (Jung et al., 2005; Bali et 
al., 2009; Yoluk et al., 2013). 
Another uncertainty is the position of TM4 in these channels (Bertaccini et al., 
2010). Studies using voltage-clamp fluorometry have reported differences between the 
GlyR α1 and α3 subunits with respect to the relative orientation and proximity of TM3 
and TM4, whereby fluorescence-tagged TM3 and TM4 residues in the α1 subunit 
exhibited intra-subunit facing orientation under glycine-dependent conditions whereas 
homologous α3 residues displayed evidence of differing orientation (Han et al., 2013). 
High resolution structures of GLIC, ELIC and GluCl find TM4 to be tilted away from the 
other three TM regions (Bocquet et al., 2009; Hilf and Dutzler, 2009; Hibbs and Gouaux, 
2011) and the intra-subunit binding site for desflurane in GLIC appears to be formed 
primarily by TM1-3 (Nury et al., 2011). It is possible that the tilt of TM4 away from the 
other TMs allows it to be partially or completely surrounded by lipid (Baenziger and 
Corringer, 2011). However, data from cross-linking experiments in the GlyR show that 
TM3 and TM4 are in sufficient proximity to allow cross-linking not only with HgCl2, but 
in the case of A288C/Y410C, also with an oxidizing agent (McCracken et al., 2010). 
Propyl methanethiosulfonate labeling experiments indicate that W407C, I409C, Y410C 
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and K411C are accessible to this reagent and are likely exposed to water, which is 
consistent with this region of TM4 contributing to a water-filled cavity (Lobo et al., 
2006). It seems likely that TM4 has considerable flexibility and may approach the other 
TMs, perhaps during gating, which is supported by the observation that cross-linking for 
A288C/Y406C and A288C/I409C are only observed if the receptor is activated by 
glycine (McCracken et al., 2010). Moreover, it is tempting to speculate that alcohols and 
anesthetics are able to stabilize the open state of the GlyR given this state creates a closer 
orientation of TM4 to the other TMs, which would allow for stronger binding to an intra-
subunit pocket formed by all four TM segments.  
 In summary, we found that the formation of a cross-linking between A288 in 
TM3 with residues Y406, W407, I409, or Y410 in TM4 reduces the ability of alcohol or 
anesthetic to enhance GlyR function. Moreover, using immunoblotting we provide 
evidence that this cross-linking appears to occur within a subunit, suggesting that TM3 





CHAPTER IV: DISCUSSION AND IMPLICATIONS 
 
In the absence of a GlyR crystal structure, the orientation of the TM amino acids 
critical for alcohol and anesthetic action have been controversial, and ultimately the 
positioning of the putative drug binding cavity within the GlyR has remained uncertain.  
The purpose of this project was to investigate whether biochemical cross-links are formed 
between residues within the same subunit (intra-subunit) or between subunits (inter-
subunit), and ultimately to determine whether these residues are participating in a 
common alcohol/anesthetic binding cavity within or between GlyR subunits (or both). 
We found that the formation of a cross-link between I229 in TM1 and A288 in 
TM3 reduced the ability of butanol or isoflurane to modulate GlyR function. Similarly, 
we have also shown that residues Y406, W407, I409, and Y410 in TM4 are able to form 
cross-links with A288 in TM3 (McCracken et al., 2010), and this cross-linking between 
TM3 and residues in TM4 in the present study also reduced the ability of alcohol or 
anesthetic to bind and produce its effect. Moreover, we found specific evidence that 
cross-linking between TM1 and TM3 appears to be inter-subunit, but intra-subunit for 
TM3 and TM4, suggesting that TM1-3 may participate in an alcohol and anesthetic 
binding cavity between GlyR subunits while TM3-4 may contribute to a binding cavity 
within a subunit. Taken together, our findings are in general agreement with the recent 
“multisite” hypothesis positing that alcohol and anesthetics act at both inter- and intra-
subunit sites on ligand-gated ion channels. This hypothesis has been generated largely by 
mutagenesis studies in the GLIC, ELIC, and GluCl homologues, molecular simulations, 
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and newer homology modeling based on the known prokaryotic/invertebrate structures. It 
expands upon the initial structures co-crystallized with drug molecules bound at either an 
intra-subunit or inter-subunit cavity (Howard et al. 2011; Murail et al., 2012; Spurny et 
al., 2013; Yoluk et al., 2013). 
 Although the general structural features of pentameric ligand-gated ion channels, 
including the GlyR and other members of the Cys-loop family, have been established and 
fairly well accepted, especially since the emergence of the 4Å resolution structure of the 
Torpedo nAChR, technical challenges have created barriers in membrane protein 
crystallography limiting the advancement and production of x-ray structures for the 
mammalian ligand ion channels (Carpenter et al., 2008), particularly GlyRs and 
GABAARs. Despite these challenges, the use of homology modeling combined with 
studies using mutagenesis and alkyl thiol reagents and/or oxidizing agents have been 
reasonably successful over the past 10+ years at helping to identify critical amino acid 
residues for alcohol and anesthetic action at multiple sites throughout the GlyR and its 
relatives. Primarily, residues in the TM segments have received the most attention and 
support (Mihic et al., 1997; Mascia et al., 2000; Lobo et al., 2006; Harris et al., 2008; Li 
et al., 2010; Duret et al., 2011; Borghese et al., 2012), but also sites such as A52 in the N-
terminal domain (Davies et al., 2004; Crawford et al., 2007) and K385 the intracellular 
loop linking TM3 and TM4 have been proposed to play a role in alcohol modulation 
(Yvenes et al., 2003; Yvenes et al., 2008). 
Recently, the known crystal structures for the two prokaryotic homologues, ELIC 
GLIC (Hilf and Dutzler, 2008; Hilf and Dutlzer, 2009; Bocquet et al., 2009), and the 
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invertebrate GluCl (Hibbs and Gouaux, 2011) have provided improved templates and 
better informed homology modeling for the study of GlyRs and related mammalian ion 
channels. These homologues and their known structures have also advanced the study of 
structure-function in the alcohol and anesthetic fields. For example, the determination of 
atomic-resolution anesthetic-bound and alcohol-bound GLIC structures (Nury et al., 
2011; Sauguet et al., 2013) as well as an anesthetic-bound ELIC structure (Spurny et al., 
2013) have recently begun to help further our understanding of the sites of alcohol and 
anesthetic action in the related ion channels and improve the characterization of drug 
binding. And while these known structures have provided solutions to previous alignment 
quandaries and have helped to pinpoint relevant sites for putative binding cavities with 
greater efficiency, these known prokaryotic sequences and their x-ray structures, in 
reality, also still represent models of the GlyR and related proteins found in higher order 
organisms, despite reasonably high predictive validity.  As such there are some 
differences worth noting between the mammalian anion-selective channels such as the 
GlyR and GABAAR and the prokaryotic channels GLIC and ELIC.  
First, GLIC is a cation-sensitive channel gated by protons, which contains a short, 
truncated-like intracellular loop domain that differs from its mammalian homologues, 
(Bocquet et al., 2009) and possesses some unique pharmacological features. Both general 
anesthetics and ivermectin inhibit GLIC function (Weng et al., 2010; Duret et al., 2011), 
which is opposite to the potentiating effects of these drugs on wild-type GlyRs and 
GABAA. In addition, wild-type GLIC is insensitive to pharmacologically relevant 
concentrations of ethanol, however Howard et al. (2011) demonstrated potentiation with 
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higher, anesthetic-range concentrations of ethanol or methanol while longer chain n-
alcohols produced inhibition. Notably though, more pharmacologically relevant 
potentiating drug effects have been a reported from a GLIC chimera harboring the human 
α1 GlyR TM domain. Like wild-type GlyRs, a variety of modulators potentiate the 
function of this chimera, including alcohols, anesthetics, and ivermectin (Duret et al. 
2011), underscoring the obligatory role of the GlyR TM domain in the potentiating 
effects of these allosteric modulators. Similarly, ELIC is also a cation-selective ion 
channel, whose atomic-resolution structure was determined prior to that of GLIC (Hilf 
and Dutzler, 2008), but difficulty identifying agonists to gate the channel made GLIC 
more popular and practical for physiological studies. High µM-mM concentrations of 
GABA, along with other primary amines, have since been shown to behave as agonists at 
ELIC (Zimmermann and Dutzler, 2011), while ethanol and anesthetics inhibit ELIC 
function (Spurny et al., 2013).  Given these characteristics, GLIC and ELIC may be the 
closest model for the human nAChR, rather than GlyR or GABAARs.   
Nevertheless, recent co-crystallization studies in GLIC and ELIC with anesthetics 
and alcohols (or their derivatives) have provided valuable structural insight to help better 
understand how and where these drugs are interacting with related human ligand-gated 
ion channels, including the GlyR. In the initial finding by Nury et al. (2011), both the 
volatile anesthetic desflurane and the intravenous anesthetic propofol were reported to 
occupy an intra-subunit cavity.  Subsequently, an ethanol-sensitized GLIC variant was 
also co-crystallized with ethanol, bromoethanol, and bromoform, which revealed primary 
occupancy of an inter-subunit binding cavity, although in the ethanol-sensitized variant, 
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both bromo-ethanol and bromoform were retained in the intra-subunit cavity as well 
(Sauguet et al., 2013). Moreover, the crystallization of ELIC in complex with bromoform 
resulted in the observation of anomalous density in multiple regions of the protein 
indicative of binding.  These predominantly included a hydrophobic pocket in the 
extracellular domain between β7-β10 strands, the channel pore, and a novel, more deeply 
situated inter-subunit TM site (Spurny et al., 2013).  However, there was no evidence of 
bromoform retained in the intra-subunit cavity in the case of ELIC, which could reflect 
the conformational/state-dependent differences between ELIC and GLIC (Spurny et al., 
2013).  Figure 4.1 provides a general overview of the different general anesthetic binding 
sites revealed by crystal structures of GLIC and/or ELIC (note that ethanol is 
unfortunately not included, however it shares many overlapping inter-subunit and intra-
subunit sites as discussed above).  
Although the present study did not address possible alcohol and anesthetic sites 
outside of the TM domain, our findings appear to be consistent with a multisite model in 
the GlyR. In functional studies of GLIC, the delineation of a potentiating inter-subunit 
cavity and an inhibitory intra-subunit cavity have been proposed (Murail et al., 2012; 
Sauguet et al., 2013). This was developed largely from the observation that introduction 
of the single F14’A point mutation in GLIC results not in only potentiation rather than 
inhibition by alcohol and anesthetics, but at much more relevant concentrations (Howard 
et al., 2011; Sauguet et al., 2013).  Moreover, molecular simulations have expanded upon 
this and even generated models for GlyRs and GABAARs (Murail et al., 2012), however 
inconsistencies among experimental data involving the mutagenesis of conserved sites 
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directly identified in the anesthetic-bound crystal structures have made the identification 
and proposal for the intra-subunit inhibitory site in GLIC a bit weaker (Ghosh et al., 
2013). Furthermore, in GABAAR experiments similar those conducted in the present 
study, Borghese et al. (2014) reported evidence of both inter-subunit and intra-subunit 
alcohol/anesthetic binding, but found no relationship between where the anesthetic binds 
and the type of modulation they produce (potentiation vs. inhibition). Similarly, the 
modulation we observed in GlyRs was consistently potentiating in nature for both alcohol 
and volatile anesthetics. However, future studies may be necessary to further investigate 
whether a precise relationship exists between where alcohols/anesthetics bind (inter-
subunit vs. intra-subunit) in the GlyR and the type of modulation the produce 
(potentiation vs. inhibition).  
In conclusion, we provide evidence that alcohols and anesthetics act at both inter- 
and intra-subunit cavities in the GlyR, which is generally consistent with multisite 
models derived from the known sequences and structures of bacterial and other 
invertebrate homologues. The use of these structures as templates for related higher order 
ion channels such as the GlyR allows for greater efficiency in the study of alcohol and 
anesthetic sites and mechanisms. Moreover, their continued use and refinement may one 
day offer a more viable approach toward the development of novel, safer general 





Figure 4.1. Overview of anesthetic binding sites in pentameric ligand-gated ion channels. 
Graphic representation is based on the known ELIC structure. Two adjacent subunits are 
shown in red and blue, and drugs placed schematically and labeled accordingly. (ES) = 
Extracellular site; (PS) = Pore site; (IS) = Inter-subunit site; Note the propofol-desflurane 
Intra-subunit site is drawn with a representative drug molecule bound, but not labeled. 
(Adapted from Spurny et al., 2013).   
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